Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  Aphria Inc    APH   CA03765K1049

APHRIA INC

(APH)
My previous session
Most popular
  Report  
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

APHRIA ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Aphria Inc. - APHA

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/11/2019 | 11:51pm EDT

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 4, 2019 to file lead plaintiff applications in a securities class action lawsuit against Aphria Inc. (NYSE: APHA), if they purchased the Company’s securities between July 17, 2018 and December 4, 2018, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

Get Help

Aphria investors should visit us at https://www.claimsfiler.com/cases/view-aphria-inc-securities-litigation or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.

About the Lawsuit

Aphria and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On December 3, 2018, Hindenburg Research reported in an article entitled “Aphria: A Shell Game with a Cannabis Business on the Side,” that an extensive investigation revealed that “Aphria is part of a scheme orchestrated by a network of insiders to divert funds away from shareholders into their own pockets” and detailing the questionable value of its investments.

On this news, the price of Aphria’s shares plummeted.

The case is Gloschat v. Aphria Inc. et al, 18-cv-11427

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.

To learn more about ClaimsFiler, visit www.claimsfiler.com.


© Business Wire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on APHRIA INC
03/04APHRIA : Receives Health Canada License Amendment, Approving Fully Expanded Prod..
AQ
02/20COMPASS DIVERSIFIED : Tilray to buy hemp food maker for about C$419 million, sha..
RE
02/15APHRIA : says review reveals conflict of interest of directors in acquisition
AQ
02/08APHRIA : Appoints Brett D. Marchand as Senior Vice President of Supply Chain
AQ
02/06APHRIA : board rejects hostile takeover offer by Green Growth Brands
AQ
02/06Aphria rejects Green Growth's hostile takeover bid
RE
02/03APHRIA 24 HOUR DEADLINE ALERT : Approximately 24 Hours Remain; ClaimsFiler Remin..
BU
02/01APHRIA 72 HOUR DEADLINE ALERT : Approximately 72 Hours Remain; Former Louisiana ..
BU
01/31APHRIA : Most actively traded companies on the TSX
AQ
01/24SCOTT+SCOTT ATTORNEYS AT LAW LLP : Reminds Investors of Securities Class Actions..
BU
More news
Financials (CAD)
Sales 2019 257 M
EBIT 2019 -57,8 M
Net income 2019 86,0 M
Finance 2019 178 M
Yield 2019 -
P/E ratio 2019 39,38
P/E ratio 2020 34,63
EV / Sales 2019 12,4x
EV / Sales 2020 4,20x
Capitalization 3 352 M
Chart APHRIA INC
Duration : Period :
Aphria Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 16,8  CAD
Spread / Average Target 25%
EPS Revisions
Managers
NameTitle
Victor Neufeld Chief Executive Officer & Director
Jakob Ripshtein President
Irwin David Simon Independent Chairman
Cole Cacciavillani Director & Vice President-Growing Operations
Carl A. Merton Chief Financial Officer
Sector and Competitors
1st jan.Capitalization (M$)
APHRIA INC0.00%2 507
CANOPY GROWTH CORP67.99%15 809
AURORA CANNABIS INC88.50%9 675
BEIJING TONGRENTANG CO., LTD.10.80%6 234
DONG-E-E-JIAO CO LTD--.--%4 713
HUTCHISON CHINA MEDITECH LIMITED27.86%3 910